Keywords
Gestosis score, uterine artery pulsatility index, gestational hypertension, high-risk pregnancy
This article is included in the Datta Meghe Institute of Higher Education and Research collection.
Gestosis score, uterine artery pulsatility index, gestational hypertension, high-risk pregnancy
As outlined by the American College of Obstetrics and Gynaecology (ACOG), gestational hypertension is defined as systolic blood pressure of 140mmHg or more or diastolic blood pressure of 90mmHg or more on two instances of at least four hours apart after 20 weeks of gestation of pregnancy in previously normotensive women.1 When this high blood pressure is associated with proteinuria, it is known as preeclampsia.
Gestational hypertension is a major medical problem during pregnancy, with possible adverse implications on both mother's and fetal health.2–4 It is critical to predict and identify high-risk pregnancies early to provide proper monitoring and care. The pooled prevalence of Hypertensive disorders of pregnancy (HDOP) in India is 9% (95% CI, 8%–10%), which is significantly higher than the global prevalence, as reported in a study done in pregnant women of the Indian population.5
Many initiatives have been carried out to anticipate and avert the onset of gestational hypertension and other pregnancy-related hypertensive disorders of pregnancy because of their epidemiological and clinical significance. In clinical settings, a variety of predictive multiparametric algorithms are employed. These algorithms utilize multiple maternal risk factors, radiological evaluations such as the uterine artery Doppler pulsatility index, and diverse plasma biomarkers to achieve their intended purpose.6–13 Despite the rising efficacy of these approaches, the actual predictive models for gestational hypertension are still a source of contention and hence not yet used in routine clinical practice.
Hence there is a need to analyze and promote newer predictive models which can help in predicting the occurrence of hypertensive disorders during pregnancy.
The purpose of this clinical study is to examine the effectiveness of two prediction approaches, the Gestosis Score and the Uterine Artery Pulsatility Index, in predicting the risk of developing gestational hypertension in pregnant women in the second trimester between the gestational age of 13 weeks to 20 weeks.
Gestosis score is a newly developed scoring system consisting of known and newly emerging risk factors for gestational hypertension developed by Dr. Gorakh Mandrupkar and modified by the FOGSI-ICOG committee (Table 1).14 The gestosis score is proposed to ensure accurate screening and prediction of gestational hypertension and hypertensive disorders of pregnancy.
This scoring system takes into account both established and newly recognized factors that are linked to the causation of gestational hypertension. The score of 1, 2, or 3 for each clinical risk factor is determined based on its impact on the development of gestational hypertension. After conducting a thorough assessment and gathering detailed medical histories of the women, a cumulative score is determined for each participant. Women with a total score of 1 will be labeled low risk, a score of 2 will be labeled moderate risk and women with a total score of 3 or more will be labelled at high risk for development of gestational hypertension. As per one Indian study a gestosis score of 3 or more, appears to have promising diagnostic accuracy (95.35%) for predicting the development of preeclampsia (PE). It demonstrates good sensitivity (83.1%) and specificity (97.51%). The study showed the PPV of gestosis score in predicting preeclampsia is 85.51%, representing the likelihood of a positive result, while the NPV is 97.03%, indicating the probability of a negative result. This suggests it may be a useful early marker for identifying the risk of gestational hypertension and preeclampsia.15
Uterine artery Doppler velocimetry will be performed in the same women using a transabdominal probe. The pulsatility index will be measured in both uterine arteries and the mean will be calculated. Reference values for uterine artery pulsatility index are different for different gestational ages. Women with a mean pulsatility index more than the 95th percentile of the reference range for the given gestational age will be labeled as high risk and other women with a pulsatility index within the normal level that is below the 95th percentile will be labeled as mild risk for development of gestational hypertension.16
All these women will be routinely monitored during each ANC visit, blood pressure will be monitored regularly to detect de novo development of hypertension during their pregnancy.
1. To evaluate the effectiveness of the Gestosis Score in predicting gestational hypertension.
2. To assess the effectiveness of the Uterine Artery Pulsatility Index in predicting gestational hypertension.
3. To compare the predictive ability of the Gestosis Score and Uterine Artery Pulsatility Index in identifying women at risk of developing gestational hypertension.
Registration: The trial has been registered with CTRI (REF/2023/04/065978).
This study will be a prospective observational study. The study will be conducted in the Department of Obstetrics and Gynaecology, Acharya Vinoba Bhave Rural Hospital, Sawangi, Wardha, India and will be conducted from 2023 to 2024 (two years).
At the end of this study, we will know whether the gestosis score has better predictive values as compared to the uterine artery pulsatility index in predicting gestational hypertension.
a. Demographic data (age, weight, height, BMI).
b. Medical history and obstetric history.
c. Data needed to detect risk factors as per gestosis score (parity, utilization of assisted reproductive technology, family history of hypertension, history of psychiatric illness)
d. Blood pressure measurements at regular intervals during antenatal visits.
e. Gestosis Score assessment during the antenatal visit.
f. Uterine Artery Pulsatility Index measurements through ultrasonography.
Pregnant women visiting antenatal clinic at Acharya Vinoba Bhave Rural Hospital, Sawangi, Wardha will be examined. After obtaining informed written consent, 140 pregnant women who meet the specific inclusion criteria will be included in the study. Their uterine artery pulsatility index and the presence of a notch will be assessed using ultrasound. Pregnant women with a mean pulsatility index higher than the 95th percentile will be classified as high-risk, while those with a mean pulsatility index lower than the 95th percentile will be categorized as low-risk. The same participants will be carefully assessed for risk factors as per the gestosis scoring system. All pertinent statistical data will be gathered during the study.14 The pregnant women will be categorized into three risk groups based on their gestosis scores: low risk (gestosis score of 1), moderate risk (gestosis score of 2), and high risk (gestosis score of 3 or higher). The participants will be followed up until six weeks after delivery. On every follow-up, blood pressure will be checked to look for hypertension.
In this study, the Daniel formula17 is employed to determine the required sample size using a prevalence rate of 9% for gestational hypertension.
“n” represents the necessary sample size,
Z is a statistical value to determine the level of confidence. In the case of a 95% confidence level, the Z-value is 1.96.
P value is the Estimated prevalence of gestational hypertension (proportion of pregnant women with gestational hypertension), which is 9% or 0.09 in this case.
And d is desired margin of error (precision), which is 5% or 0.05 in this case.
Therefore, the sample size required is 126 pregnant women for the study with a prevalence of 9%.
Based on the prevalence of gestational hypertension (9%) and desired precision (5%), the calculated sample size is approximately 126 pregnant women. The target enrolment will be set at 140 participants to account for potential attrition and data loss.
Chi-square test and students paired t-test will be used to analyze the data.
The collected data will be organized in an Excel sheet and a master chart will be generated for further analysis. The statistical analysis will be conducted using SPSS version 27 software, considering a desired error margin and a confidence interval of 95%.
All collected data will be stored securely, and participant identities will be kept confidential.
Approval from the Institutional Ethical Committee has been obtained before enrolling any participants in the study. Informed written consent will be obtained from each participant.
Ethical approval has been obtained for this study from the institutional ethical committee of Datta Meghe Institution of Higher Education and Research (approval: ECR/440/Inst/2013/RR-2019) on 21/07/2022.
The results of this study will be published in an indexed journal for wider dissemination and accessibility and presented at relevant scientific conferences to contribute to the existing body of knowledge on gestational hypertension prediction.
A limitation of this study is the small sample size and the fact it is a single centre study.
Larger sample size and multicentric studies will be needed to apply study results in wider population.
This research may lead to improved early detection and intervention strategies for gestational hypertension, potentially reducing adverse maternal and fetal outcomes.
Gestosis score14 (https://m.apkpure.com/hdp-gestosis-score/hdp.gestosis.score).
As gestational hypertension has morbid consequences on the outcome of pregnancy, there is a need not only for diagnosis and management of gestational hypertension but also for methods that will help in identifying women who may develop gestational hypertension in pregnancy. This study evaluates the predictive abilities of two such methods, gestosis score with uterine artery pulsatility index with the expected outcome of gestosis score being better radiological evaluation in detecting at-risk pregnant women. This study will help in employing gestosis score as a screening method at health centers where ultrasonography or other expensive biochemical investigations cannot be done.
High-risk pregnancies will be diagnosed earlier and managed accordingly to provide healthy outcomes and safe motherhood to women.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Partly
References
1. Cavoretto PI, Salmeri N, Candiani M, Farina A: Reference ranges of uterine artery pulsatility index from first to third trimester based on serial Doppler measurements: longitudinal cohort study.Ultrasound Obstet Gynecol. 2023; 61 (4): 474-480 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Maternal Fetal Medicine
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |
---|---|
1 | |
Version 1 05 Oct 23 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)